- Home
- MGIC vs AMLX Comparison
MGIC vs AMLX Comparison
Compare MGIC & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGIC
- AMLX
- Stock Information
- Founded
- MGIC 1983
- AMLX 2014
- Country
- MGIC Israel
- AMLX United States
- Employees
- MGIC N/A
- AMLX N/A
- Industry
- MGIC Computer Software: Prepackaged Software
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- MGIC Technology
- AMLX Health Care
- Exchange
- MGIC Nasdaq
- AMLX Nasdaq
- Market Cap
- MGIC 788.0M
- AMLX 749.9M
- IPO Year
- MGIC 1991
- AMLX 2022
- Fundamental
- Price
- MGIC $19.64
- AMLX $10.20
- Analyst Decision
- MGIC Buy
- AMLX Strong Buy
- Analyst Count
- MGIC 2
- AMLX 7
- Target Price
- MGIC $18.00
- AMLX $12.29
- AVG Volume (30 Days)
- MGIC 44.1K
- AMLX 1.3M
- Earning Date
- MGIC 08-13-2025
- AMLX 08-07-2025
- Dividend Yield
- MGIC 2.90%
- AMLX N/A
- EPS Growth
- MGIC 16.93
- AMLX N/A
- EPS
- MGIC 0.78
- AMLX N/A
- Revenue
- MGIC $584,528,000.00
- AMLX N/A
- Revenue This Year
- MGIC $11.11
- AMLX N/A
- Revenue Next Year
- MGIC $6.83
- AMLX N/A
- P/E Ratio
- MGIC $24.99
- AMLX N/A
- Revenue Growth
- MGIC 11.98
- AMLX N/A
- 52 Week Low
- MGIC $10.24
- AMLX $2.09
- 52 Week High
- MGIC $22.00
- AMLX $10.20
- Technical
- Relative Strength Index (RSI)
- MGIC 45.20
- AMLX 69.71
- Support Level
- MGIC $19.10
- AMLX $9.15
- Resistance Level
- MGIC $20.85
- AMLX $10.06
- Average True Range (ATR)
- MGIC 0.52
- AMLX 0.54
- MACD
- MGIC -0.09
- AMLX 0.12
- Stochastic Oscillator
- MGIC 42.01
- AMLX 98.53
About MGIC Magic Software Enterprises Ltd.
Magic Software Enterprises Ltd is a software development company. The company's operating segment includes Software Services and IT Professional Services. The company generates maximum revenue from the IT Professional Services segment. IT Professional Services segment offers IT services in the areas of infrastructure design and delivery, application development, technology planning and implementation services, communications services and solutions, as well as supplemental outsourcing services. Geographically, it derives a majority of revenue from the United States and also has a presence in Israel, Europe, Japan, and Other countries.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.